Illumina Inc
Illumina Inc is a Life Sciences Tools & Services company listed on NASDAQ NMS - GLOBAL MARKET.
Industry
Life Sciences Tools & Services
Exchange
NASDAQ NMS - GLOBAL MARKET
Market Cap
$31.2B
P/E Ratio
—
Cash on Hand
Not available
Shares Outstanding
151.3M shares
Currency
USD
About
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
via Wikipedia →Earnings (EPS)
QuarterEPS EstimateEPS Actual
Q2 2026$1.25$1.31
Q1 2026$1.08$1.15
Q4 2025$1.08$1.15
Q3 2025$1.19$1.34
Analyst Insights
Insider Activity
Recent buys and sells by company executives and directors — publicly disclosed, as required by law.
Meister Keith A.
Aug 27, 2026 • $226.74/share
Sold 4,873
Meister Keith A.
Aug 27, 2026 • $227.67/share
Sold 54,309
Meister Keith A.
Aug 27, 2026 • $228.64/share
Sold 24,363
Meister Keith A.
Aug 27, 2026 • $229.72/share
Sold 16,990
Meister Keith A.
Aug 27, 2026 • $230.54/share
Sold 28,439
Meister Keith A.
Aug 27, 2026 • $231.23/share
Sold 9,405
Recent News
This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday
Benzinga • Sep 11
Transcriptome Sequencing Market - Global Forecast to 2035; Bulk RNA-Seq Maintains Its Technology Market Lead
Yahoo • Sep 10
This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Benzinga • Sep 10
S&P Dow Jones Indices CEO on Index Restructuring
Yahoo • Sep 9
Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now
Yahoo • Sep 9